The Global Standard Certification Institute announced on June 1 that it will host a business briefing on the U.S. FDA OTC registration support initiative from 3:00 PM to 4:30 PM at Maison de Ivoire (T Tower 1512) in Gyeonggi Gwangmyeong. This event is specifically designed for companies that have been selected for the '2026 FDA OTC support initiative', aimed at assisting South Korean beauty and over-the-counter pharmaceutical enterprises in successfully penetrating the U.S. market.

Diving into the core aspects of the FDA OTC support initiative, the briefing will also elucidate the specialized benefits provided to selected companies alongside a detailed timeline of forthcoming activities. This structured approach signals a commitment to not just demystifying regulatory complexities but also to enhancing the strategic positioning of participating firms.

Moreover, a focused Q&A session is planned to address the pressing concerns and challenges faced by these businesses in their operational environments. This interaction is pivotal, as it fosters knowledge transfer while equipping companies with actionable insights to navigate the U.S. regulatory landscape more effectively.

OTC products encompass a range of legally purchasable medicines without the need for a physician's prescription, including sunscreen, BB cream with SPF, anti-dandruff and hair loss prevention shampoos, acne treatments, hand sanitizers, toothpaste, and topical ointments. For South Korean firms aspiring to enter the U.S. cosmetics and OTC markets, achieving FDA OTC registration is a critical milestone that must be accomplished.

Global Standard Certification Institute is equipped with a systematic OTC registration framework to support companies wishing to enter the U.S. market. This program emphasizes comprehensive consulting beyond mere documentation services, offering practical solutions to navigate stringent U.S. regulations and ensure successful manufacturing facility registrations.

With an established presence and a network of FDA agents in the U.S., the institute distinguishes itself through specialized knowledge. It swiftly disseminates vital information regarding evolving FDA OTC regulations and market trends to the domestic beauty sector, reinforcing K-beauty’s global market footprint.

Jae-geum Jeon, the representative of Global Standard Certification Institute, commented, 'The U.S. market is the largest beauty and healthcare sector globally, but without a precise understanding of FDA OTC regulations, companies may encounter significant entry barriers. Through this briefing, we intend to minimize the learning curve for selected companies, enabling them to secure solid competitiveness in the U.S. market through thorough preparation and comprehensive support.'